Weifeng Xu
About
In The Last Decade
Weifeng Xu
71 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 119
- Molecular Biology 1.1k
- Cellular and Molecular Neuroscience 592
- Oncology 196
- Cardiology and Cardiovascular Medicine 182
- Pharmacology 155
Countries citing papers authored by Weifeng Xu
This map shows the geographic impact of Weifeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Xu more than expected).
Fields of papers citing papers by Weifeng Xu
This network shows the impact of papers produced by Weifeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Xu. The network helps show where Weifeng Xu may publish in the future.
Co-authorship network of co-authors of Weifeng Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Xu. A scholar is included among the top collaborators of Weifeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Xu. Weifeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 10 | |
| 4 | 7 | |
| 5 | 4 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 11 | |
| 10 | 5 | |
| 11 | 1 | |
| 12 | 36 | |
| 13 | 9 | |
| 14 | 35 | |
| 15 | 26 | |
| 16 | 10 | |
| 17 | 11 | |
| 18 | 1 | |
| 19 | 10 | |
| 20 | [Anti-proliferation of human cervical cancer HeLa cell line by fascaplysin through apoptosis induction]. | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.